We are very pleased to announce that Snowdome, in conjunction with the Leukaemia Foundation, are funding RAVEN, a new, national paediatric trial for Australian children with relapsed or refractory acute lymphoblastic leukaemia (ALL). This is the first study of its kind to look at the effectiveness of a combination treatment to overcome chemotherapy resistance in children and young people with relapsed ALL. This trial aims to bring hope to the...

In 2010 chimeric antigen receptor T-cell (CAR T-cell) therapy was very experimental.  It had only been tested in mice but two gentlemen who had...

The results of ELARA, a large international trial investigating the treatment of relapsed or refractory follicular lymphoma (FL) with chimeric antigen receptor T-cell therapy...